XEOS is focused on improving outcomes in surgical oncology by leveraging the power of molecular imaging in the operating room. The company’s AURA 10 specimen PET-CT imager provides surgeons with an immediate 3-dimensional visualization of the resected tissue specimen at the point of surgery. This information helps the surgeon ensure that a complete resection is obtained. Promising results have been obtained in head and neck cancer surgery.